Hendrik Grub

Company: Heidelberg Pharma

Job title: Director, Chemistry

Seminars:

Discovering a Novel Mechanism of Action for ADC Payloads by Using Amatoxins as RNA Polymerase II Inhibitors 2:30 pm

Understanding why we chose to inhibit RNA-Polymerase II and the unique mode of action of amatoxins Identifying useful biomarkers to evaluate amatoxin susceptibility in tumors Outlining the benefits of adapting a novel payload with unique mode of action vs. a well understood, clinically validated drugRead more

day: Conference Day One